Enbrel etanercept: Phase IV data

In an open-label Phase IV extension study in 46 evaluable patients, 78% of patients achieved

Read the full 157 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE